Natixis Advisors LLC bought a new stake in Maximus, Inc. (NYSE:MMS – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 10,247 shares of the health services provider’s stock, valued at approximately $955,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Assenagon Asset Management S.A. grew its stake in shares of Maximus by 151.6% during the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after purchasing an additional 140,481 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of Maximus by 942.9% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock worth $27,707,000 after purchasing an additional 292,300 shares during the period. Tidal Investments LLC grew its stake in shares of Maximus by 238.9% during the first quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 8,997 shares during the period. SG Americas Securities LLC grew its stake in shares of Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock worth $1,224,000 after purchasing an additional 12,266 shares during the period. Finally, Versor Investments LP grew its stake in shares of Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider’s stock worth $792,000 after purchasing an additional 5,789 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.
Maximus Stock Down 0.5 %
Shares of Maximus stock opened at $72.50 on Thursday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 12 month low of $71.75 and a 12 month high of $93.97. The business has a fifty day simple moving average of $87.49 and a 200 day simple moving average of $87.86. The stock has a market cap of $4.37 billion, a PE ratio of 14.42 and a beta of 0.77.
Maximus Announces Dividend
Insiders Place Their Bets
In other Maximus news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $607,841.52. The trade was a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.40% of the company’s stock.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- What Are Trending Stocks? Trending Stocks Explained
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The Most Important Warren Buffett Stock for Investors: His Own
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.